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Abstract. Metal nanoparticles can be functionalized with biomolecules to selectively localize in precancerous
tissues and can act as optical contrast enhancers for reflectance-based diagnosis of epithelial precancer. We carry
out Monte Carlo (MC) simulations to analyze photon propagation through nanoparticle-labeled tissues and to
reveal the importance of using a proper form of phase function for modeling purposes. We first employ modified
phase functions generated with a weighting scheme that accounts for the relative scattering strengths of unlabeled
tissue and nanoparticles. To present a comparative analysis, we repeat our MC simulations with simplified functions
that only approximate the angular scattering properties of labeled tissues. The results obtained for common optical
sensor geometries and biologically relevant labeling schemes indicate that the exact form of the phase function
used as model input plays an important role in determining the reflectance response and approximating functions
often prove inadequate in predicting the extent of contrast enhancement due to labeling. Detected reflectance
intensities computed with different phase functions can differ up to ∼60% and such a significant deviation
may even alter the perceived contrast profile. These results need to be taken into account when developing
photon propagation models to assess the diagnostic potential of nanoparticle-enhanced optical measurements.
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1 Introduction
Naturally existing or inherent contrast between optical signals
obtained from normal and precancerous tissues is due to mor-
phological, structural, and biochemical changes associated with
cancer progression.1, 2 There is currently a significant interest
to develop optically active, molecular-specific contrast agents
that selectively bind to cancer biomarkers in tissues and en-
hance intrinsic optical signals.3–5 Metal nanoparticles can act
as contrast enhancers when functionalized with biomolecules to
specifically target cancer cells. These particles absorb and scat-
ter light with distinct spectral features that can be exploited for
reflectance-based diagnosis of precancer.6–9
Numerous computational and experimental studies have
been performed to analyze the resonant optical properties of
nanoparticles.10–18 These studies describe the sensitivity of the
absorption and scattering characteristics of nanoparticles to their
size, shape, composition, and aggregation state as well as to
the dielectric structure of the surrounding medium. Numerical
results obtained with Mie theory, discrete dipole approxima-
tion, or the T-matrix approach provide an extensive insight into
the resonance behavior and the relative extinction efficiency of
nanospheres, nanorods, nanoshells, and even stellated nanos-
tructures as a function of wavelength.
Characterization of the resonant response of metal nanoparti-
cles to electromagnetic radiation in the visible and near-infrared
range is a key step in understanding their potential as optical con-
trast agents. However, a complete assessment of the extent of
Address all correspondence to: Dizem Arifler, Eastern Mediterranean Univer-
sity, Department of Physics, Famagusta, Cyprus; Tel: ( + 90) 392-630-1060; Fax:
( + 90) 392-365-1604; E-mail: dizem.arifler@emu.edu.tr.
achievable contrast enhancement requires a detailed analysis of
photon propagation at the bulk or macroscopic tissue level. If tis-
sues are to be labeled with nanoparticles for diagnostic purposes,
the differential optical effect due to addition of these exogenous
contrast enhancers needs to be quantified. Modeling studies to
predict the overall reflectance profile of tissues in the presence
of nanoparticles are likely to reveal the level of exogenous con-
trast that can be attributed to precancer development. This is
particularly important for optical interrogation techniques that
are based on diffuse or multiply scattered light.19, 20
The Monte Carlo (MC) method provides a powerful compu-
tational tool to model the reflectance profile of tissues. Due to its
flexibility in handling complicated tissue constructs or source-
detector geometries, it has been extensively used to quantify and
contrast optical signals obtained from normal and precancerous
tissues.21–24 MC modeling can also be adapted to account for
the additional optical effect of external labeling and to study
photon propagation in tissues labeled with metal nanoparticles.
Lin et al.25 have employed MC models to simulate how tissue
reflectance changes with varying nanoshell size and concentra-
tion. Their results indicate that only a very small concentration
of gold nanoshells is sufficient to alter the reflectance response
of tissues. The simulations performed also demonstrate the
importance of considering absorption by nanoshells even when
optical extinction is dominated by scattering. It should be noted,
however, that this study makes simplifying assumptions about
the angular scattering properties of nanoparticle-labeled tissues;
the authors argue that the anisotropy factor of tissues does
not significantly change when the volume fraction of added
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nanoparticles is small and they use the well-known Henyey-
Greenstein (HG) phase function to describe the probability
of scattering at different angles. From a theoretical point of
view, the anisotropy factor needs to be modified in accordance
with a weighting scheme that takes into account the relative
scattering strengths of unlabeled tissue and nanoparticles rather
than their respective volume fractions.26 Further, although HG
phase functions are frequently used to approximate the angular
scattering probability distributions of tissue scatterers, they
may not be sufficient to characterize the angular scattering
properties of tissues labeled with nanoparticles. Nanoparticles
exhibit almost isotropic scattering due to their small size and
when these particles are added to highly forward scattering
tissues, the resulting profile of angular scattering may no longer
be represented by an HG function. A recent study by Kortun
et al.27 has shown that subtle differences in the shape of phase
functions may translate into significant changes in detected
reflectance intensity and the extent of these changes depends
on the optical sensor geometry. Therefore, even though the
approximations employed in the cited study may prove valid for
the scenarios considered, a more comprehensive investigation is
needed.
Another MC study reported by Kirillin et al.28 analyzes the
contrasting properties of gold nanoshells and titanium diox-
ide nanoparticles for optical coherence tomography imaging.
The simulation results show that image contrast increases af-
ter addition of nanoparticles and the level of contrast en-
hancement predicted by MC simulations agrees well with ex-
perimental images. The modeling strategy described accounts
for the presence of nanoparticles by defining preset proba-
bilities of scattering by a tissue element or by an embedded
nanoparticle. Scattering by a tissue element is characterized
by an HG phase function, whereas the angular distribution of
light scattered by a nanoparticle is computed using Mie the-
ory. This methodology is theoretically more appropriate, but
the results presented do not offer any insight into whether
such a detailed approach is requisite for simulating common
optical detection systems and biologically relevant labeling
schemes.
The goal of the research presented in this paper is to carry out
MC simulations and analyze the influence of the phase function
on the modeled optical response of nanoparticle-labeled tis-
sues. We construct normal and precancerous epithelial tissue
models consisting of a thin epithelium on top of an underly-
ing stromal layer and we consider labeling of precancerous ep-
ithelium with varying concentrations of gold nanospheres that
have different sizes. Scattering in unlabeled epithelium is as-
sumed to be characterized by an HG function and phase func-
tions of nanospheres are calculated using Mie theory. When
nanospheres are added to the epithelium, the modified phase
functions can then be generated by combining these two compo-
nents based on their respective scattering strengths. We employ
an MC algorithm that allows random sampling of scattering
directions directly from the generated functions and we com-
pute reflectance signals at different wavelengths. The optical
sensor geometries tested involve perpendicular or tilted fibers
with varying source-detector separations. To present a compar-
ative analysis, we repeat our MC simulations using HG func-
tions with identical anisotropy factors as the modified phase
functions.
Table 1 Optical properties of normal and precancerous epithelial
tissue (Ref. 22).
λ = 540 nm λ = 560 nm λ = 600 nm
Normal Precancer Normal Precancer Normal Precancer
μs1 (cm− 1) 33.0 99.0 31.8 95.4 29.7 89.1
μa1 (cm− 1) 1.8 1.8 1.6 1.6 1.4 1.4
g1 0.95 0.95 0.95 0.95 0.95 0.95
μs2 (cm− 1) 207.1 155.3 199.7 149.8 186.4 139.8
μa2 (cm− 1) 3.73 7.46 3.11 6.22 1.46 2.92
g2 0.88 0.88 0.88 0.88 0.88 0.88
2 Methods
2.1 Monte Carlo Modeling
The fixed-weight MC code used in this study was implemented
in C/C ++ and has been detailed elsewhere.22, 27 Tissue layers
are assumed to be infinitely wide and parallel to each other. Each
layer is described by a thickness d and several optical prop-
erties including the refractive index n, absorption coefficient
μa, scattering coefficient μs, and scattering phase function p,
where the integer subscript  indicates the layer number. The
phase function specifies the probability of scattering in a given
direction and can be considered to represent angular distribution
of scattered light during photon propagation. If the tissue layer
is isotropic in terms of physical properties and there is no direc-
tional alignment of tissue components, p depends only on the
deflection angle θ .29 The azimuthal scattering angle is generally
assumed to be uniformly distributed between 0 and 2π . Our
MC implementation allows simulations to be carried out with
the well-known HG phase function or any phase function given
in discretized form. In either case, the anisotropy factor g is
defined as the expected value of cosθ .29
All the simulations presented in this work were carried out
with 108 input photons. Each simulation was repeated three
times and the results shown represent averages over these three
simulations. Standard errors were also computed to provide ev-
idence for convergence of MC modeling results.
2.2 Epithelial Tissue Parameters
2.2.1 Normal and precancerous tissue properties
Epithelial tissue was modeled as a two-layer medium with 
= 1, 2. The top cellular epithelium was assigned a thickness of
d1 = 300 μm. The thickness of the stromal layer underneath the
epithelium was set to a large value to mimic d2 = ∞. The two
tissue layers were index matched with n1 = n2 = 1.35. Table 1
lists the scattering coefficients, absorption coefficients, and the
anisotropy factors of normal and precancerous tissue at three
different wavelengths, namely λ = 540, 560, and 600 nm. Note
that precancerous tissue is characterized by a three-fold increase
in epithelial scattering, a 25% decrease in stromal scattering, and
a two-fold increase in stromal absorption. These optical changes
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accompany structural and morphological alterations in epithe-
lial cell nuclei, remodeling of the stromal collagen matrix, and
increased hemoglobin content in the stroma, respectively, and
have been observed to provide a realistic representation of pre-
cancer development.22 The anisotropy factors were assumed to
be wavelength independent with g1 = 0.95 and g2 = 0.88 for
both normal and precancerous tissue. The HG phase function
was used to describe the angular scattering probability distribu-
tions in the epithelial and stromal layers. This is an analytical
function that specifies the probability that a photon is scattered
in the angular interval (θ , θ + dθ ) and is expressed as27, 29
p(θ ) = 1 − g
2

2(1 + g2 − 2g cos θ )3/2
sin θ, (1)
such that ∫ π
0
p(θ )dθ = 1. (2)
2.2.2 Nanoparticle-labeled precancerous
tissue properties
We assume that when metal nanoparticles are added to tissue,
they will selectively attach to cancer cells and will eventually
be distributed throughout the precancerous epithelium. This is
a simple and yet realistic approximation since nanoparticles
can be functionalized to specifically bind to cellular biomarkers
that are overexpressed in epithelial precancers.3–9, 15, 16, 18 While
the stromal optical properties remain unchanged, the scatter-
ing and absorption properties of precancerous epithelium need
to be modified to account for the additional optical effect of
these particles. Let μnps and μ
np
a be the differential scattering
and absorption coefficients due to the addition of nanoparticles,
respectively. Under the assumption of independent scattering,








where Csca and Cabs are the scattering and absorption cross sec-
tions of nanoparticles, f is the volume fraction of nanoparticles
added to the epithelial layer, and V is the volume occupied by
a single nanoparticle. The modified scattering and absorption
coefficients are then given by
μ∗s1 = μs1 + μnps ; μ∗a1 = μa1 + μnpa . (4)
The modified phase function can be calculated by adopting
a weighting scheme that accounts for the relative scattering
strengths of unlabeled epithelium and nanoparticles. If the phase
function of nanoparticles is denoted by pnp, the modified phase
function of the epithelial layer can be computed as26
p∗1 =
μs1 p1 + μnps pnp
μ∗s1
. (5)
Note that the anisotropy factor of the nanoparticle-labeled ep-
ithelium is given by
g∗1 =
μs1g1 + μnps gnp
μ∗s1
, (6)
where gnp is the anisotropy factor of nanoparticles.
In this study, we considered nanoparticles in the form of
gold nanospheres with diameters of 40, 80, and 120 nm. The
values of the complex dielectric function for gold were obtained
from experimental data reported by Johnson and Christy.30
These values were then corrected for intrinsic size effects as
described by Averitt et al.,31 Link and El-Sayed,32 and Berciaud
et al.33 Although the corrections were minimal even for 40-nm
nanospheres, it was necessary to incorporate intrinsic size ef-
fects for generality and completeness. Since nanospheres were
to be added to the epithelial layer, they were assumed to be
embedded in a medium with a refractive index of n1 = 1.35
and their optical properties were computed using Mie theory
for homogeneous spherical scatterers.34 Mie theory calculations
were performed for optical wavelengths in increments of 20 nm
and the results showed that 40-, 80-, and 120-nm nanospheres
had maximum scattering cross sections at λ = 540, 560, and
600 nm, respectively. The influence of phase function on mod-
eled optical response of nanoparticle-labeled tissues is likely to
be most pronounced where nanoparticles exhibit strong scatter-
ing. Hence, these three representative wavelengths were selected
for MC simulations presented in this paper.
Three different volume fractions were tested to assess the
effect of particle concentration on epithelial optical properties.
These volume fractions were f1 = 0.0005%, f2 = 0.001%, and f3
= 0.005%. Note that the percentages given correspond to about
1.5×1011 to 1.5×1012 particles/mL for 40-nm nanospheres,
1.9×1010 to 1.9×1011 particles/mL for 80-nm nanospheres, and
5.5×109 to 5.5×1010 particles/mL for 120-nm nanospheres, and
are comparable to concentration ranges reported in previous ex-
perimental and computational studies.7, 15, 18, 20, 25, 28, 35 At such
low concentrations, the assumption of independent scattering is
justifiable and the modified optical properties can be calculated
according to Eqs. (3)–(6).
It is important to note that since Mie theory can only be used
to compute the intensity of scattered light at discrete angles, care
must be taken to ensure proper normalization of modified phase
functions given by Eq. (5). Assume that the intensity of light
scattered by nanospheres is denoted by I(θ ), where θ ∈ {0, 1,
. . ., 180} is the scattering angle in degrees. The scattering phase
function pnp is then calculated as
pnp(θ ) = I (θ ) sin θθ∑180
θ=0 I (θ ) sin θθ
. (7)
The angular interval θ equals 1 and cancels out in
Eq. (7), but it has been included for completeness. Similarly,
a discretized version of Eq. (1) can be used to express p1 for θ
∈ {0, 1, . . ., 180}. The modified phase function p∗1 will then be
defined only for discrete directions, but continuous scattering
angles can still be obtained via a random-variate generation al-
gorithm applied in conjunction with an interpolation scheme.27
Simulations for nanoparticle-labeled precancerous tissue
were carried out with modified epithelial phase functions com-
puted using Eq. (5). These simulations were then repeated with
g∗1 -equivalent HG functions to present a comparative analysis.
2.3 Optical Sensor Parameters
It is well established that the probing depth of a given source-
detector fiber pair depends on the separation and angular orien-
tation of the fibers.22, 36 Optical sensor geometries that preferen-
tially probe the top epithelial layer are expected to demonstrate
a greater degree of sensitivity to the form of the phase function
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Table 2 Modified optical properties of precancerous epithelium labeled with 40-, 80-, and 120-nm gold
nanospheres. Three different volume fractions are considered: f1 = 0.0005%, f2 = 0.001%, and f3 =
0.005%.
λ = 540 nm λ = 560 nm λ = 600 nm
f1 f2 f3 f1 f2 f3 f1 f2 f3
40 nm
μ∗s1 (cm
− 1) 99.4 99.8 103.2 95.7 96.0 98.6 89.2 89.4 90.5
μ∗a1 (cm
− 1) 6.5 11.3 49.3 4.2 6.8 27.7 2.1 2.7 7.9
g∗1 0.95 0.94 0.91 0.95 0.94 0.92 0.95 0.95 0.94
80 nm
μ∗s1 (cm
− 1) 101.3 103.5 121.6 98.3 101.3 124.7 90.9 92.7 107.2
μ∗a1 (cm
− 1) 5.3 8.8 36.8 4.8 7.9 33.1 2.5 3.6 12.2
g∗1 0.93 0.91 0.78 0.92 0.90 0.73 0.93 0.91 0.79
120 nm
μ∗s1 (cm
− 1) 100.8 102.7 117.3 97.9 100.4 120.3 92.5 95.8 122.7
μ∗a1 (cm
− 1) 3.0 4.2 13.7 2.6 3.6 11.8 2.1 2.8 8.4
g∗1 0.93 0.92 0.81 0.93 0.90 0.76 0.92 0.88 0.69
used for nanoparticle-labeled precancerous epithelium. In order
to assess the extent of geometry-dependent influence of epithe-
lial phase function on detected reflectance, we modeled two fiber
optic probe configurations that are commonly employed for
optical measurements. Both configurations consisted of a single
source fiber and multiple detector fibers positioned at different
distances from the source. The fibers were all in contact with the
tissue surface and they were assigned a diameter of 100 μm and
a numerical aperture of 0.11 (in air). The refractive indices of
the fibers were set to 1.5 and the material between the fibers was
index matched to the epithelial layer to mimic a highly absorp-
tive interface. In the first configuration, the source and detector
fibers were perpendicular to the tissue surface. In the second
configuration, the fibers were oriented such that the distal ends of
a given source-detector fiber pair were tilted toward each other.
Each fiber made an angle of 30 deg with respect to the tissue
normal, but the fiber tips remained parallel to the tissue surface.
For the two configurations described, we present and discuss re-
sults for center-to-center source-detector separations of 150 and
300 μm.
3 Results
3.1 Modified Optical Properties of
Nanoparticle-Labeled Precancerous Epithelium
Table 2 lists the modified optical properties of precancerous ep-
ithelium labeled with 40-, 80-, and 120-nm nanospheres. The
results show that the scattering and absorption coefficients can
significantly change when nanoparticles are added to the ep-
ithelial layer. As expected, the extent of these changes depends
on the size and concentration of the nanoparticles as well as
the wavelength. The largest incremental increase in the epithe-
lial scattering coefficient occurs at λ = 540, 560, and 600 nm
for 40-, 80-, and 120-nm nanospheres, respectively. The most
significant increase in the epithelial absorption coefficient, on
the other hand, is observed at λ = 540 nm for all nanospheres.
It is also evident that the addition of nanoparticles can lead
to a substantial decrease in the anisotropy factor and this ap-
pears to be most pronounced at wavelengths corresponding to
respective scattering cross section maxima. Overall, modifica-
tions for the absorption coefficient are more extensive when
small nanospheres are added, whereas larger nanospheres tend
to produce more significant changes in the scattering coefficient
and the anisotropy factor.
Figures 1–3 provide representative examples to illustrate how
the phase function of precancerous epithelium changes due to
the addition of nanoparticles. Figure 1 presents the results ob-
tained at λ = 540 nm for varying concentrations of 40-nm
nanospheres. Each plot shows the HG phase function char-
acterizing unlabeled epithelium, the Mie phase function of a
single 40-nm nanosphere, the modified phase function calcu-
lated using Eq. (5), and an HG phase function with an identical
anisotropy factor as the modified phase function. For all of the
plots presented, the angular resolution for the scattering an-
gle is 1 deg. Note that the probability of scattering at 0 and
180 deg is zero due to the inclusion of the sinθ factor in
Eqs. (1) and (7), and these data points have been excluded from
the semilog plots. For f1 = 0.0005% [Fig. 1(a)], the addition of
40-nm nanospheres does not affect the epithelial phase function
over the angular range ∼0 to 90 deg, but there is a slight increase
in scattering probability for larger angles; the g∗1 -equivalent
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Fig. 1 Modified phase functions of precancerous epithelium labeled
with 40-nm gold nanospheres and their g∗1-equivalent HG counterparts
for λ = 540 nm. The HG function characterizing unlabeled precancer-
ous epithelium (g1 = 0.95) and the Mie phase function of a single
40-nm nanosphere (gnp = 0.0016) are also shown. Three different vol-
ume fractions are considered: (a) f1 = 0.0005%; g∗1 = 0.95, (b) f2= 0.001%; g∗1 = 0.94, and (c) f3 = 0.005%; g∗1 = 0.91.
















































































Fig. 2 Modified phase functions of precancerous epithelium labeled
with 80-nm gold nanospheres and their g∗1-equivalent HG counterparts
for λ = 560 nm. The HG function characterizing unlabeled precancer-
ous epithelium (g1 = 0.95) and the Mie phase function of a single
80-nm nanosphere (gnp = 0.0049) are also shown. Three different vol-
ume fractions are considered: (a) f1 = 0.0005%; g∗1 = 0.92, (b) f2= 0.001%; g∗1 = 0.90, and (c) f3 = 0.005%; g∗1 = 0.73.
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Fig. 3 Modified phase functions of precancerous epithelium labeled
with 120-nm gold nanospheres and their g∗1-equivalent HG counter-
parts for λ = 600 nm. The HG function characterizing unlabeled pre-
cancerous epithelium (g1 = 0.95) and the Mie phase function of a
single 120-nm nanosphere (gnp = 0.0067) are also shown. Three dif-
ferent volume fractions are considered: (a) f1 = 0.0005%; g∗1 = 0.92,
(b) f2 = 0.001%; g∗1 = 0.88, and (c) f3 = 0.005%; g∗1 = 0.69.
HG function falls short of predicting this high-angle scattering
enhancement. The results for f2 = 0.001% [Fig. 1(b)] show
similar trends, but there are larger differences between the mod-
ified phase function and its g∗1 -equivalent HG counterpart. For f3
= 0.005% [Fig. 1(c)], the addition of 40-nm nanospheres leads
to a significant increase in scattering probability for angles
>∼30 deg; with the g∗1 -equivalent HG phase function, the scat-
tering probability is underestimated for <∼10 deg, overesti-
mated over the angular range ∼10 to 90 deg, and underestimated
again for >∼90 deg.
Similarly, Fig. 2 shows the modified phase functions ob-
tained at λ = 560 nm for varying concentrations of 80-nm
nanospheres. Progressively increasing levels of high-angle scat-
tering enhancement are observed for f1 = 0.0005% [Fig. 2(a)],
f2 = 0.001% [Fig. 2(b)], and f3 = 0.005% [Fig. 2(c)]. In addi-
tion to a significant increase in high-angle scattering probability,
the modified phase function for f3 = 0.005% is also character-
ized by a discernible drop in scattering probability for angles
<∼30 deg. With the respective g∗1 -equivalent HG phase func-
tions, the scattering probability is underestimated for <∼10 deg,
overestimated over the angular range ∼10 to 90 deg, and un-
derestimated again for >∼90 deg; the extent of these deviations
increases with increasing volume fraction.
Finally, Fig. 3 presents the results obtained at λ = 600 nm
for varying concentrations of 120-nm nanospheres. The mod-
ified phase functions are similar to those shown in Fig. 2 for
80-nm nanospheres, but the level of high-angle scattering en-
hancement is considerably higher. It is also apparent that the
differences between the modified phase functions and their
g∗1 -equivalent HG counterparts are more extensive for 120-nm
nanospheres.
3.2 Influence of Phase Function on Modeled
Reflectance
Figures 4–7 show the modeled reflectance response for different
source-detector geometries simulated. For each labeling scheme
considered, the simulation results for normal and unlabeled pre-
cancerous tissue are plotted along with the results for labeled
precancerous tissue in order to enable a relative assessment of
intensity differences. Note that the reflectance values in each fig-
ure have been scaled such that the intensity at λ = 600 nm equals
one for normal tissue. In all cases, the error bars corresponding
to standard error values computed over three simulations are the
same size as or smaller than the symbols shown. The dashed
lines connecting the data points for modified and g∗1 -equivalent
HG phase functions are meant to guide the eye and highlight the
influence of phase function on the reflectance profile of labeled
precancerous tissue.
The results presented in Fig. 4 demonstrate that when the
fibers are oriented perpendicular to the tissue surface and are
separated by a distance of 150 μm, the reflectance intensity of
unlabeled precancerous tissue is lower compared to that of nor-
mal tissue. The addition of 40-nm nanospheres enhances this
negative contrast by causing a further reduction in detected re-
flectance intensity and it is evident that the form of the phase
function used does not have any influence on simulation out-
put [Figs. 4(a)–4(c)]. Similar trends are observed for 80-nm
nanospheres added at low concentrations [Figs. 4(d)–4(e)], but
the results are sensitive to the form of the phase function used
Journal of Biomedical Optics August 2011  Vol. 16(8)085002-6
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 9/28/2017 Terms of Use: https://spiedigitallibrary.spie.org/ss/TermsOfUse.aspx
Cihan and Arifler: Influence of phase function on modeled optical response of nanoparticle-labeled epithelial tissues











normal precancer, unlabeled precancer, labeled (modif ied) precancer, labeled (g1
*-equivalent HG)
























































































Fig. 4 Modeled reflectance response of normal tissue, unlabeled precancerous tissue, and precancerous tissue labeled with gold nanospheres.
Possible combinations of nanosphere sizes (40, 80, and 120 nm) and volume fractions (f1 = 0.0005%, f2 = 0.001%, and f3 = 0.005%) result in
nine different labeling schemes: (a) 40 nm; f1, (b) 40 nm; f2, (c) 40 nm; f3, (d) 80 nm; f1, (e) 80 nm; f2, (f) 80 nm; f3, (g) 120 nm; f1, (h) 120 nm; f2,
and (i) 120 nm; f3. The source and detector fibers are oriented perpendicular to the tissue surface and are separated by a center-to-center distance
of 150 μm.
when the volume fraction is high; the most significant difference
appears at λ = 560 nm, where the intensity obtained with the
HG phase function is ∼40% higher than that obtained with the
modified phase function [Fig. 4(f)]. Interestingly, the addition of
120-nm nanospheres at low concentrations does not lead to any
contrast enhancement [Figs. 4(g)–4(h)]. For the highest volume
fraction tested, however, the use of different phase functions
can give rise to considerable intensity variations; most notably,
the intensity obtained with the modified phase function at λ
= 600 nm suggests a reduction of negative signal contrast,
whereas the intensity obtained with the HG phase function is
∼35% higher and points to a positive contrast relative to normal
tissue [Fig. 4(i)].
Figure 5 shows the reflectance response for perpendicular
source and detector fibers separated by a center-to-center dis-
tance of 300 μm. The basic trends are similar to those presented
in Fig. 4 for a source-detector separation of 150 μm, but dif-
ferences between the simulation results for modified and HG
phase functions are more significant when 120-nm nanospheres
are added at the highest volume fraction shown; for instance, the
intensities obtained with HG phase functions are ∼60% higher
at λ = 560 and 600 nm and this alters the perceived contrast
profile [Fig. 5(i)].
The results corresponding to tilted fibers with a center-
to-center source-detector separation of 150 μm are shown in
Fig. 6. Note that the vertical scale for each subplot has been
adjusted so that intensity differences due to labeling can be
clearly identified. When the fibers are tilted with respect to
the tissue surface, the reflectance intensity of unlabeled pre-
cancerous tissue is higher compared to that of normal tissue
and, hence, the inherent diagnostic contrast is positive. It ap-
pears that this source-detector geometry is highly sensitive to
the form of the phase function used to simulate labeled tissue;
considerable differences arise for all of the labeling schemes
considered. Particularly for 80- and 120-nm nanospheres, both
forms of phase function point to an increase in detected re-
flectance intensity relative to unlabeled tissue, but positive con-
trast enhancement predicted with modified phase functions is
consistently higher than that predicted with their g∗1 -equivalent
HG counterparts. The largest differences (∼35%) occur at λ =
560 nm when 80-nm nanospheres are added at a volume fraction
of f2 = 0.001% [Fig. 6(e)] and at λ = 600 nm when 120-nm
nanospheres are added at a volume fraction of f1 = 0.0005%
[Fig. 6(g)].
Figure 7 depicts the modeled reflectance response when the
separation between tilted source and detector fibers is increased
Journal of Biomedical Optics August 2011  Vol. 16(8)085002-7
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 9/28/2017 Terms of Use: https://spiedigitallibrary.spie.org/ss/TermsOfUse.aspx
Cihan and Arifler: Influence of phase function on modeled optical response of nanoparticle-labeled epithelial tissues











normal precancer, unlabeled precancer, labeled (modif ied) precancer, labeled (g1
*-equivalent HG)
























































































Fig. 5 Modeled reflectance response of normal tissue, unlabeled precancerous tissue, and precancerous tissue labeled with gold nanospheres.
Possible combinations of nanosphere sizes (40, 80, and 120 nm) and volume fractions (f1 = 0.0005%, f2 = 0.001%, and f3 = 0.005%) result in
nine different labeling schemes: (a) 40 nm; f1, (b) 40 nm; f2, (c) 40 nm; f3, (d) 80 nm; f1, (e) 80 nm; f2, (f) 80 nm; f3, (g) 120 nm; f1, (h) 120 nm; f2,
and (i) 120 nm; f3. The source and detector fibers are oriented perpendicular to the tissue surface and are separated by a center-to-center distance of
300 μm.
to 300 μm. Note again that the vertical scales have been adjusted
to maintain clarity of the plots. These results further illustrate
that intensity changes predicted with different forms of phase
function can appreciably vary, especially for larger nanospheres.
As in Fig. 6, the largest relative differences (∼25%) occur at λ
= 560 nm when 80-nm nanospheres are added at a volume
fraction of f2 = 0.001% [Fig. 7(e)] and at λ = 600 nm when
120-nm nanospheres are added at a volume fraction of f1
= 0.0005% [Fig. 7(g)].
As a supplementary summary of the main trends observed
in Figs. 4–7, Table 3 lists sample simulation results to illustrate
possible extent of the influence of phase function on modeled
optical response of labeled tissues. In all cases, the reflectance
values have been scaled such that the intensity for normal tissue
equals one. The percentages included in parentheses reiterate
the degree of overprediction by the respective phase function.
4 Discussion
The results presented in this study indicate that computational
analysis of photon propagation through nanoparticle-labeled
tissues requires a meticulous consideration of model input. The
addition of nanoparticles can significantly alter the scattering
and absorption coefficients as well as the anisotropy factor, but
our results reveal that the exact form of the phase function used
to model labeled tissues can also play an important role in de-
termining the reflectance response. Further, it is evident that the
extent of the influence of phase function is highly dependent on
the optical sensor geometry simulated.
When the fibers are oriented perpendicular to the tissue sur-
face, the inherent diagnostic contrast is negative; most of the
detected photons penetrate deep into the stroma and the drop
in intensity with development of precancer is due to increased
stromal absorption and reduced stromal scattering.22, 27 It has
been previously shown that tilted fibers demonstrate preferen-
tial sensitivity to the top epithelial layer. In this case, the inherent
diagnostic contrast is expected to be positive; detected photons
are mostly confined to the epithelium and increased epithelial
scattering associated with development of precancer gives rise
to higher intensity values.27, 36 Even though the main motivation
behind nanoparticle labeling is to enhance the inherent contrast
for improved diagnosis, the results in Figs. 4–7 demonstrate
that the interplay of coincident changes in epithelial scattering
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Fig. 6 Modeled reflectance response of normal tissue, unlabeled precancerous tissue, and precancerous tissue labeled with gold nanospheres.
Possible combinations of nanosphere sizes (40, 80, and 120 nm) and volume fractions (f1 = 0.0005%, f2 = 0.001%, and f3 = 0.005%) result in nine
different labeling schemes: (a) 40 nm; f1, (b) 40 nm; f2, (c) 40 nm; f3, (d) 80 nm; f1, (e) 80 nm; f2, (f) 80 nm; f3, (g) 120 nm; f1, (h) 120 nm; f2, and (i)
120 nm; f3. The distal ends of the source and detector fibers are tilted toward each other and are separated by a center-to-center distance of 150 μm.
and absorption properties can lead to geometry-dependent con-
trast trends. For perpendicular fibers, a nanoparticle-induced
increase in epithelial absorption may have a dominating in-
fluence on the reflectance profile causing a negative contrast
enhancement. This is especially pertinent to 40- and 80-nm
nanospheres, whereas the overall effect of labeling with 120-nm
nanospheres is quite unpredictable. For tilted fibers, on the other
hand, a nanoparticle-induced increase in epithelial scattering
may have a dominating influence causing a positive contrast en-
hancement. Labeling schemes that employ 120-nm nanospheres
exhibit this trend, but we note that the effect of adding 40- or
80-nm nanospheres is hard to predict since the observed con-
trast profile is also dependent on the source-detector separation
considered.
Intensity variations arising from the use of different phase
functions, however, are directly traceable to the results displayed
in Figs. 1–3. Perpendicular fibers are particularly sensitive to
near-forward (<∼10 deg) and backward (>∼160 deg) scatter-
ing events. For most labeling schemes, modified phase functions
exceed their g∗1 -equivalent HG counterparts over these angular
ranges. It appears that higher forward scattering probability pre-
dicted with modified phase functions is the dominant factor that
affects the reflectance profile; photons are directed into deeper
tissue regions giving way for more extensive absorption and,
hence, the detected reflectance intensity is lower. With the cor-
responding HG functions, lower forward scattering probability
suggests that detected photons tend to remain at more superficial
tissue depths and, hence, MC results point to higher intensity
levels. Differences in forward scattering probability are most
pronounced for larger spheres added at the highest volume frac-
tion considered and these translate into more significant changes
in MC output.
It has been reported that fibers tilted at 30 deg demonstrate
enhanced sensitivity to the phase function over the angular
range ∼100 to 150 deg.27 When the source and detector fibers
are very close to each other, the majority of detected photons
undergo a single intermediate-angle scattering event in the
epithelium and the scattering angle falls into the specified range.
For all of the labeling schemes tested, scattering probability
over this angular range is higher for modified phase functions
compared to their HG counterparts. Hence, it is not surprising
at all that MC simulations carried out with modified phase
functions predict higher intensity levels. If the source-detector
separation is larger, photons may first experience near-forward
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Fig. 7 Modeled reflectance response of normal tissue, unlabeled precancerous tissue, and precancerous tissue labeled with gold nanospheres.
Possible combinations of nanosphere sizes (40, 80, and 120 nm) and volume fractions (f1 = 0.0005%, f2 = 0.001%, and f3 = 0.005%) result in nine
different labeling schemes: (a) 40 nm; f1, (b) 40 nm; f2, (c) 40 nm; f3, (d) 80 nm; f1, (e) 80 nm; f2, (f) 80 nm; f3, (g) 120 nm; f1, (h) 120 nm; f2, and (i)
120 nm; f3. The distal ends of the source and detector fibers are tilted toward each other and are separated by a center-to-center distance of 300 μm.
scattering before deflecting through ∼100 to 150 deg toward
the detector. In this case, higher forward scattering probability
characterizing modified phase functions will increase the
penetration depth making photons more prone to absorption.
Depending on the labeling scheme considered, these competing
factors may result in no observable difference in the reflectance
intensity computed with modified and HG phase functions.
Overall, even though it is easier to compute the modified
anisotropy factor and describe the angular scattering proper-
ties of labeled tissues with an analytical HG phase function,
our results indicate that such an approximation may lead to
incorrect and sometimes misleading model predictions regard-
ing the expected contrast profile. We note, however, that MC
modeling studies presented in this work employed a series of
assumptions that merit discussion. First, labeling was specific to
precancerous tissue and distribution of nanoparticles was uni-
form throughout the entire thickness of the epithelial layer. As
indicated earlier, nanoparticles can be attached to molecules
that have high affinity for cellular cancer biomarkers and vari-
ous conjugation strategies have also been developed to reduce
nonspecific labeling.3–9, 15, 16, 18 Uniform epithelial delivery, on
the other hand, can be achieved through administration of per-
meation enhancers.37 A common target in diagnostic studies
is epidermal growth factor receptor (EGFR), which is overex-
pressed in epithelial precancers; significant labeling is observed
when gold nanoparticles conjugated to anti-EGFR are added
to precancerous tissue samples, whereas labeling is much less
pronounced in normal samples.6, 38 In applications involving
systemic delivery, passive extravasation from leaky vasculature
aids in selective accumulation of nanoparticles in precancerous
tissue.9, 35 For topical applications, some deposition of particles
might inevitably occur in normal tissue, but there is currently no
quantitative information and, hence, no indication as to whether
any such unwanted deposition can alter the conclusions of this
study. In modeling labeled precancerous tissue, we did not con-
sider any potential influence of particle spacing and our calcu-
lations were based on the assumption of low volume fraction
and, hence, independent scattering. It is known that interparticle
effects become significant for center-to-center distances of less
than about three times the particle radius.18 When gold nanopar-
ticles are conjugated to anti-EGFR, for instance, labeling pre-
dominantly occurs on the cell membrane.6, 38 This is the type
of labeling strategy we envision and nanoparticle volume frac-
tions we simulate are so low that a rough estimation for 10-μm
cells points to a surface coverage of less than 5% in all cases.
Under these conditions, it is highly unlikely that interparticle
Journal of Biomedical Optics August 2011  Vol. 16(8)085002-10
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 9/28/2017 Terms of Use: https://spiedigitallibrary.spie.org/ss/TermsOfUse.aspx
Cihan and Arifler: Influence of phase function on modeled optical response of nanoparticle-labeled epithelial tissues
Table 3 Sample simulation results to illustrate possible extent of the influence of phase function on modeled optical response of tissues labeled
with gold nanospheres. The three different volume fractions indicated are: f1 = 0.0005%, f2 = 0.001%, and f3 = 0.005%. In all cases, the reflectance
values have been scaled such that the intensity for normal tissue equals one. The percentages in parentheses specify the degree of overprediction by
the respective phase function.
Reflectance intensity relative to normal tissue
Optical sensor
geometry Labeling scheme λ (nm) Precancer, unlabeled Precancer, labeled (modified) Precancer, labeled (g∗1-equivalent HG)
Perpendicular fibers
separated by 150 μm
80 nm; f3 560 0.57 0.26 0.36 (∼40%)
Perpendicular fibers
separated by 150 μm
120 nm; f3 600 0.63 0.88 1.19 (∼35%)
Perpendicular fibers
separated by 300 μm
80 nm; f3 600 0.63 0.29 0.41 (∼40%)
Perpendicular fibers
separated by 300 μm
120 nm; f3 540 0.56 0.28 0.40 (∼40%)
Perpendicular fibers
separated by 300 μm
120 nm; f3 560 0.54 0.34 0.54 (∼60%)
Perpendicular fibers
separated by 300 μm
120 nm; f3 600 0.63 0.47 0.76 (∼60%)
Tilted fibers separated
by 150 μm
80 nm; f2 560 2.43 5.77 (∼35%) 4.25
Tilted fibers separated
by 150 μm
120 nm; f1 600 2.40 5.22 (∼35%) 3.86
effects will have any implications on the results presented here.
Previous studies suggest that internalization of EGFR and the
resulting biomarker-mediated aggregation of nanoparticles in
small organelles can lead to a red shift in scattering maxima
along with a considerable increase in scattering cross section
per particle.5, 6, 8, 15, 16, 18, 38 Aggregation effects are also evident
when nanoparticles are targeted to intracellular biomarkers such
as human papillomavirus related oncoproteins.38 Details regard-
ing specific aggregation patterns are largely unknown and our
study does not address this issue. We can, however, hypothesize
that the influence of phase function will be even more exten-
sive in situations where particle aggregation causes increased
scattering. Finally, we used nanospheres as labeling agents to
demonstrate the importance of generating a proper form of phase
function. Nanospheres are commonly encountered and yet sim-
ple to analyze, but similar conclusions are expected to apply to
other types of nanoparticles such as nanorods and nanoshells
with large optical cross sections that can significantly alter the
angular scattering properties of tissues. As a side remark, metal
nanoparticles can also generate contrast by creating field en-
hancement and exciting fluorescent markers.5 Although this
study focused on analyzing the reflectance profile of labeled
tissues, it is possible to extend MC modeling and track fluores-
cence signals that would be detected in such a scenario.
5 Conclusions
The goal of the research described in this paper was to simu-
late photon propagation through nanoparticle-labeled epithelial
tissues and to reveal the importance of using a proper form of
scattering phase function for modeling purposes. As evidenced
by the results presented, approximating phase functions may
prove inadequate in predicting the extent of contrast enhance-
ment due to labeling and may even alter the perceived contrast
profile. It is also worth pointing out, once again, that the ad-
dition of nanoparticles gives rise to coincident changes in ep-
ithelial scattering and absorption properties, and whether these
changes lead to an overall increase or decrease in detected re-
flectance intensity depends on the labeling scheme considered
and the source-detector geometry simulated. Even though this
study focused on investigating the reflectance response at a few
representative wavelengths, a detailed assessment of the diag-
nostic potential of nanoparticle-enhanced measurements calls
for an extended geometry-specific spectral analysis of optical
signals obtained from labeled tissues.
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